|
|
|
(State or Other Jurisdiction of Incorporation or Organization)
|
(Commission File Number)
|
(I.R.S. Employer Identification No.)
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Title of each class
|
Trading Symbol
|
Name of each exchange on which registered
|
||
|
|
|
Item 5.02 |
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
|
Chembio Diagnostics, Inc.
|
||
Dated: October 18, 2021
|
By:
|
/s/ Richard L. Eberly
|
Chief Executive Officer and President
|
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
Document and Entity Information |
Oct. 16, 2021 |
---|---|
Cover [Abstract] | |
Document Type | 8-K |
Amendment Flag | false |
Document Period End Date | Oct. 16, 2021 |
Entity Registrant Name | CHEMBIO DIAGNOSTICS, INC. |
Entity Incorporation, State or Country Code | NV |
Entity File Number | 0-30379 |
Entity Tax Identification Number | 88-0425691 |
Entity Address, Address Line One | 555 Wireless Blvd. |
Entity Address, City or Town | Hauppauge |
Entity Address, State or Province | NY |
Entity Address, Postal Zip Code | 11788 |
City Area Code | 631 |
Local Phone Number | 924-1135 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Entity Emerging Growth Company | false |
Entity Central Index Key | 0001092662 |
Title of 12(b) Security | Common Stock, $0.01 par value |
Trading Symbol | CEMI |
Security Exchange Name | NASDAQ |
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end
^OD9ITILU;&].$J:FK+!D%3'PB6_YMAM8ED-LC\-O M@Y*0![9->1AN= >BW3GIOA2WWZ8%?7/<+O6^].5OU3R'D6U$7A!BSPAL8I,P M<)W((H[#H\ .O,<4BBK#7-:(7H)[>WK0.SSX9V$;T F17WB.CH_;7[
V$=]
MF5[G Q4ZCM2!*LOXR\.8< 7Z5:^<%<)DD:TQKEX%1
M#A<#('=7$IIY2X5AZJ=F><#I>I'DNO[6BGGKX8JQ;H^U;K1,0_48>FB_ADY9
M[P$?P47D+150P5@Q7276H!0D)U?<0Z8FR'7M;-N$>-M^V85W@50LGDRE)!,(
M KG=/8BX"!/?B_["'KU@+>JGQ J5\GA"4SEX4J%XNGYH =M7/;^ LG:/,O(H
MXF&4Q?OQ7,.TAZ3V@L-/.Y0$]<$'Z-
Z32P+3;@R)Z )[HB=CULS5E17KB19+C
M"[K).'NZH+&;=Z\1A@P:1D!5Q2F)>HFDP:'2S$_@-7--$GR[2>>8.052-AMJ
M.#9#I;XR!2^>CT
5&(215R21O_(DX\GI1O@A1:/5HZI4#]X$-T_3SCSOA-AS?I<]7?%%4(NU
M[;
^G5)/;6$P@N"*1& V"<$ND
MDQ[NP9TP/[OM^?,',_+O-43?.'MO1MJ\W06]M1=QSM6STI4J:!!_.=@^/L/^
M)&2#9R\'Z_"0\8A\G8YF<%ABH-!ET7:9Z>L0FZ1R6VI_"AW!0(/]"TG\5-U2*L"#;AY@>R=Z!8EP_I2OA
M5%-RW^(R,3&$\8EPX4TD.,G2PQ-,9^OO-FM&C;LK*5368)N'SCQD1=19X*X-
M[V0'O!8D&_'06U6DRIB>IOYDH(!@2:ONF[^<_-GJ5\X]>B\ ^E-?-0*+/2X
M=,Z76<34X9_N0*Z*A,T?G[_A(SX]"KM,!++A"D_&;5SDSH% RR&G),6F10GV
MNT:=RY\O (2NOQPG-[G?']2XQS4!@8Y? :HZHGJ]F';YT&5D,,CT %.4?#=
MW31GD\;7O=L 2&?(Y2<+0.0[J+P^U NT*#T$60]#?;')+,B[ ) :%HR%[E76-L#A_YH@T:*'*
M.^DD@TYQIQ12C2::'=FNS<^KUPQVH*V%0LOM+*ZY;863+-=NJ2WUA,&P'/ /
M0'[/-8+RI4G?5 XFD&7D:D8FQ8E2Q5;3VL/L0HR?S4V4(3^MXYID2;)V4+^;
M-QU_BA2"/EP(<:Q[F"J14U$>NS7O$XJ'%9JIY"H:XB07#:>S8F?(XTME=6J;
MGKTT_[\EVFQS%KNW,^2>+L/?K$+>JLCX1O(^IM.]EP&,0%2%RVC'R7#;2G/I
M),7&)$S>OT-0G8"[=GFMVK?I-*HI/[._K^8!3WY7Y]